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Abstract
OBJECTIVE: To investigate the underlying mecha-
nism of reduced myocardial ischemia-reperfusion
(I/R) injury in rats using the traditional Tibetan med-
icine Sanweitanxiang powder (SWTX).
METHODS: Rats were randomly divided into six
groups (n=10) as follows: (a) propranolol dinitrate
control group, given propranolol dinitrate 0.02 g/kg
for 10 days before I/R, (b) SWTX with a high dose
group, given SWTX 1.5 g/kg for 10 days before I/R,
(c) SWTX with a medium dose group, given SWTX
1.25 g/kg for 10 days before I/R, (d) sham group
(Sham), in which the rat heart was exposed by peri-
cardiotomy but without I/R, (e) SWTX with a low
dose group, given SWTX 1.0 g/kg for 10 days be-
fore I/R, and (f ) I/R injury group. Rats were intragas-
trically pretreated with propranolol dinitrate or
SWTX. After that, the operation to cause ischemia
and reperfusion was conducted. The histopatholog-
ic changes of rat hearts were observed by hematox-
ylin and eosin staining and transmission electron
microscopy. Ca2 + homeostasis protein expression
was determined by western blot.
RESULTS: After SWTX pretreatment, the develop-
ment of ultrastructural pathological changes from
IR injury was attenuated. A decrease in the expres-
sion of B-cell lymphoma 2 associated X protein,
and an increase in the expression of B-cell lympho-
ma 2 were observed. An increased activation of ex-
tracellular signal regulated kinases were found.
Compared with the sham group, the expression of
sarcoplasmic reticulum calcium-ATPase, phosphol-
amban, and calsequestrin were all up-regulated af-
ter pretreatment with SWTX.
CONCLUSION: The protective mechanism of SWTX
pretreatment on myocardial I/R injury might be re-
lated to its effect on maintaining the balance of cal-
cium homeostasis in rat heart.
© 2013 JTCM. All rights reserved.
Key words: Reperfusion injury; Homeostasis; Pro-
tein expression; Sanweitanxiang powder
INTRODUCTION
Myocardial ischemia injury is a major consequence of
cardiovascular disease. Although the pathogenesis of
myocardial ischemic injury was reported in 1960, unre-
solved issues still exist.1-3 Percutaneous coronary inter-
vention (PCI) is one of the most effective methods
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when coronary occlusion is relieved within a critical
time window.4-6 However, reperfusion has profound
and dangerous effects on ischemic myocardium, which
are referred to as myocardial ischemia-reperfusion (I/R)
injury.7-9 Many therapeutic approaches have been ex-
plored to protect against myocardial I/R injury, such as
preconditioning and postconditioning.10-14 Among
them, pharmacological preconditioning which at-
tempts to attenuate I/R injury can be used as an effec-
tive adjunct to PCI and reperfusion.15-17
A number of Traditional Tibetan Medicines have been
used in the treatment of cardiovascular diseases with
positive effects, providing a basis for exploring pharma-
cological candidates for the treatment of I/R injury.18
Sanweitanxiang powder (SWTX) consists of Tanxiang
(Lignum Santali Albi), Guangzao (Fructus Choerospondi-
atis), and Roudoukou (Semen Myristicae Fragrantis).
SWTX has been widely used in ethnomedicine for clin-
ical therapy of cardiopyretic disease and is used by the
Qinghai and Tibetan traditional healers.19
In our previous research,19 we found that pretreatment
with SWTX reduced I/R injury in rat hearts. We ob-
served that the myocardial infarction area decreased.
The levels of malondialdehyde (MAD), nitric oxide
synthase (NOS), inducible NOS, and NO were
down-regulated and superoxide dismutase, and gluta-
thione peroxidase were up-regulated in serum. The
myocardial contraction and relaxation ability was en-
hanced after SWTX pretreatment. However, the mech-
anisms of SWTX pretreatment remain elusive. We hy-
pothesized that SWTX pretreatment induced cardio-
protection by maintaining Ca2+ homeostasis during I/R
injury. Therefore, we assayed the influence of SWTX
on the expression of proteins involved in Ca2 + homeo-
stasis.
MATERIALS ANDMETHODS
Medicines and reagents
SWTX was purchased from the Tibetan Medicine Cor-
poration (Qinghai, China). A known quantity of dried
SWTX was soaked in distilled water for 24 h at
35℃-42℃ and macerated with a mortar and pestle.
The mixture was filtered, condensed with a rotary evap-
orator, and lyophilized. The dry powder was dissolved
in distilled water at concentrations of 15% , 12.5% ,
and 10% for use. Propranolol dinitrate was purchased
from Shanxi SANPU Pharmaceutical Corporation
(Shanxi, China).
The antibodies for extracellular signal regulated kinase
(ERK) (sc-94), phosphorylation of ERK (sc-81492),
B-cell lymphoma 2 (Bcl-2) (sc-7382), sarcoplasmic re-
ticulum calcium-ATPase (SERCA2a) (sc-8094), and
phospholamban (sc-17024-R) were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA, USA).
The antibodies for calsequestrin (ab3516) and Bcl-2 as-
sociated X protein (Bax) (ab7977) were purchased
from Abcam Corporation (Cambridge, MA, USA).
ECL chemiluminescence kit was purchased from
Biyuntian Biotech Institute (Beijing, China).
Animals
Male Sprague-Dawley rats (250-300 g) were purchased
from the Experimental Animal Center at the medical
college of Lanzhou, China (Certificate of quality:
SCXK, 2009-0004). The animals were housed with a
12 h light-dark cycle at 25℃± 2℃, and in a relative hu-
midity of 30%-60%. Rats were fed ad libitum on a diet
of standard pellets and water. Experimental rats were
randomly divided into six groups (n=10): (a) proprano-
lol dinitrate control group (PC), given propranolol di-
nitrate 0.02 g/kg for 10 days before I/R, (b) SWTX
with a high dose group (HS), given SWTX 1.5 g/kg
for 10 days before I/R, (c) SWTX with a medium dose
group (MS), given SWTX 1.25 g/kg for 10 days before
I/R, (d) sham group (Sham), in which rat hearts were ex-
posed by pericardiotomy but without I/R, (e) SWTX
with a low dose group (LS), given SWTX 1.0 g/kg for
10 days before I/R, and (f ) I/R injury group. Rats were
pretreated intragastrically with Propranolol dinitrate or
SWTX.
In vivo experimental protocol
All animals were anesthetized with a single intraperito-
neal injection of urethane (1.0 g/kg). After tracheal in-
tubation, rats were ventilated by an animal artificial res-
pirator (DH1, Medical Equipment Produce Company
in Medical College of Zhejiang, China). The breathing
frequency was maintained at 55-65 breaths/min. A
lead-II electrocardiogram was used via subcutaneous
stainless steel electrodes (American Biopac System).
The body temperature of rats was maintained at 38℃
during the entire experiment process.
Ischemia and reperfusion induction
After performing a left thoracotomy and pericardioto-
my, the hearts were exposed. A suture was passed
around the left anterior descending coronary artery by
inserting a small curved prolene 6.0 needle into the
margin of the pulmonary cone, exiting through the
middle of the line linking the cone to the atrium. The
suture ends were threaded through a small vinyl tube
to prepare a snare. After surgical preparation, the rat
was allowed to stabilize for 20 min. In the experimen-
tal groups, the left anterior descending coronary artery
was occluded for 30 min by tightening the snare. Myo-
cardial ischemia was confirmed by the appearance of a
regional cyanosis and akinesia or bulging on the epicar-
dium distal to the snare. After 30 min of ischemia, the
snare was released and reperfusion was allowed for a pe-
riod of 40 min. Hemodynamic parameters were mea-
sured at: (a) 0 min before ischemia (baseline), (b) at
the end of ischemia (or no ischemia), and (c) at the
end of 40 min reperfusion.
Hematoxylin and eosin (HE) staining
After 40 min reperfusion, the heart tissues were fixed
in 10% formalin for at least 24 h, embedded in paraf-
fin, and cut into 5 µm-thick sections using a rotary mi-
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crotome. The sections were stained with HE dye and
observed under a microscope to detect histopathologi-
cal changes in the heart tissue.
Transmission electron microscopy
Small heart tissue samples about 1 mm3 were fixed in
4% glutaraldehyde, postfixed for 1 h in 1% OsO4 in
0.1 M cacodylate buffer, dehydrated, and embedded in
Epon 812 at 60℃ for 48 h. Routine 60 nm ultrathin
sections were cut and mounted on coated grids, and
stained with 1% uranyl acetate and Reynold's lead ci-
trate. Transmission electron microscopy was performed
with H 600 at 60 kV.
Western blot analysis
After the I/R experiment, the heart tissue was obtained
and total protein was extracted from the risk zones.
The myocardial tissue was placed in lysis buffer con-
taining protease inhibitors, homogenized, and centri-
fuged. The protein concentration of each sample was
determined using a bicinchoninic acid protein assay
kit. To detect the expression of ERK, phosphorylation
of ERK, Bcl-2, Bax, SERCA2a, phospholamban
(PLB), and calsequestrin (CQS), 20 µg of the total pro-
tein were electrophoresed on a 4%-12% polyacryl-
amide gel. The gels were transferred to polyvinylidene
difluoride (PVDF) membranes by electrophoretic trans-
fer and blocked for 1 h in 5% skim milk. The samples
were incubated with primary antibodies (1∶200) in
Tris Buffered Saline and Tween-20 (TBST) with 5%
bovine serum albumin (BSA) overnight at 4℃ . They
were then incubated with IgG-horseradish peroxi-
dase-conjugated secondary antibody (1∶ 5000) in
TBST with 1% BSA. The signals were detected by
ECL.
Statistical analysis
All data were expressed as the mean±SEM of results ob-
tained from the experiments. Differences between data
sets were assessed by one-way analysis of variance fol-
lowed by Newman-Keuls tests (SPSS 19, Armonk, NY,
USA). P<0.05 was considered as statistically significant.
RESULTS
SWTX pretreatment on I/R injury heart
histomorphology
Sections from the sham group displayed normal struc-
ture without pathologic changes seen under a light mi-
croscope. There was no leukocyte infiltration or necro-
sis in the sham group (Figure 1A). In the I/R injury
group, marked histopathologic changes were observed,
such as coagulation necrosis, karyolysis, disappearance
of the myocardial tissues, and apparent inflammatory
cell infiltration (Figure 1B). The extent of inflammato-
ry lesions in the LS group was significantly less severe
than in the I/R injury group (Figure 1C). Myocardial
tissue samples observed with transmission electron mi-
croscopy are shown in Figure 1D-F. Samples exhibited
a normal morphologic appearance in the sham group.
The myocytes have well-ordered myofibrils with a dis-
tinct sarcomeric registry and dark mitochondria with
tightly arranged cristae (Figure 1D). In contrast, hearts
subjected to the I/R treatment showed abnormalities
in mitochondrial and myofilament morphology. The
40 min I/R exhibited evidence of severe, irreversible
injury, including breaks in the sarcolemma, abnormal
nuclei, hyperplasia of mitochondria, and dense intrami-
tochondrial granules. Swelling and paucity of cristae
with loss of cytosolic glycogen were also found in mito-
chondria (Figure 1E). In the LS group, the myocytes
showed well-ordered myofibrils and the mitochondria
showed well-ordered arranged crista, although with a
slight paucity (Figure 1F).
Figure 1 Effect of SWTX pretreatment on histopathologic changes in myocardial I/R injury in rats tested with HE staining
(A-C, ×200) and transmission electron microscopy (D-F, ×10 000)
A, D: sham group; B, E: I/R injury group; C, F: LS group, given SWTX 1.0 g/kg for 10 days before I/R. I/R: ischemia-reperfu-
sion; LS: SWTX with a low dose; SWTX: Sanweitanxiang powder; HE: hematoxylin and eosin.
A B C
D E F
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SWTX pretreatment on activity of proteins related
to ERK
The phosphorylation activity of ERK was higher in I/R
injured hearts than in the sham group. Compared with
p44 ERK, p42 ERK was not activated significantly in
the I/R injury group. However, rat myocardium pre-
treated with 1.5 g/kg SWTX showed dramatically
higher levels of phosphorylation activity of ERK
when compared with I/R injury group and PC group
(Figure 2).
SWTX pretreatment on expression of proteins
related to apoptosis
As shown in Figure 3, I/R reduced Bcl-2 expression
and increased Bax expression. In the SWTX-pretreated
groups, the expression of Bax decreased and Bcl-2 in-
creased compared with the sham group (P<0.05).
SWTX pretreatment on expression of proteins
related to calcium homeostasis
As shown in Figure 4, I/R induced a marked decrease
in SERCA2a protein levels compared with the sham
group. In the SWTX pretreated group, this decrease of
SERCA2a was attenuated by pharmaceutical precondi-
tioning, but was still lower than that in the sham
group. PLB expression was increased significantly after
SWTX pretreatment as compared with the sham and I/
R groups (P<0.05). CQS expression increased after
SWTX pretreatment, but was still lower than that in
the I/R group.
DISCUSSION
ERK 1/2 are members of the mitogen-activated pro-
tein kinases, a family of serine-threonine kinases that
regulate cell proliferation, differentiation, and surviv-
al.20 ERK 1/2 are activated in response to I/R, oxidative
stress, and hypoxia,21 And ERK 1/2 have been shown
to mediate cellular protection during I/R.22 We mea-
sured the phosphorylation of ERK (42 and 44 kDa) by
western blot. Our results indicate that SWTX pretreat-
ment activated ERK 1/2 which could maintain myocar-
dial viability in hearts exposed to I/R injury.
Apoptosis is one of the main causes of damage after
myocardial I/R injury. It has been reported that the mi-
tochondrial permeability transition pore opening
causes heart damage by apoptosis.23 The anti-apoptotic
protein Bcl-2 has been known to attenuate cellular in-
jury by preventing injurious Ca2+ release from the endo-
plasmic reticulum and inhibiting Bax translocation
from the cytoplasm to mitochondria.24 Activation of
ERK 1/2 also inhibits the conformational change in
Bax protein thereby preventing apoptosis.25 In our
study, we found an increase in expression of Bcl-2 and
a decrease in Bax after pretreatment with SWTX
which could protect against apoptosis induced by I/R
injury and therefore prevent the heart from injury by
reperfusion.
Ca2 + is an important messenger in intracellular signal
transduction and plays an essential role in cardiac exci-
tation-contraction coupling. During the process, intra-
cellular Ca2 + homeostasis is carefully regulated by ion
channels, specific binding, and transport proteins. In-
tracellular dysregulation of Ca2 + homeostasis is pro-
posed as the mechanism of cell injury induced by I/R.26
The interruption of Ca2+ overload has been proposed as
an important target for increasing tolerance to I/R inju-
ry.27 Important Ca2+ cycling proteins such as SERCA2a,
PLB, and CQS in the sarcoplasmic reticulum play a
central role in regulating the intracellular Ca2+ concen-
tration.28 SERCA2a is the most abundant Ca2 +-ATPase
within the myocardium and the PLB is one of the key
SERCA2a regulatory proteins.29 Our previous studies
have demonstrated that SWTX pretreatment contrib-
utes to protection against I/R injury, but the effects on
Ca2 + cycling proteins have not been investigated.19 In
this study, we found that I/R injury markedly decreases
SERCA2a protein expression, and pretreatment with
SWTX could increase the expression. Meanwhile, pre-
treatment with SWTX at a dose of 1.5 g/kg significant-
ly increased PLB expression. The protective mecha-
nism of SWTX pretreatment could be related to Ca2 +
homeostasis by increasing protein content of Ca2 +-cy-
cling proteins in the sarcoplasmic reticulum. Some re-
Figure 2 Western blotting of SWTX pretreatment on phos-
phorylation activity of ERK
PC: propranolol dinitrate control group, given propranolol di-
nitrate 0.02 g/kg for 10 days before I/R; HS: SWTX with a high
dose group, given SWTX 1.5 g/kg for 10 days before I/R; MS:
SWTX with a medium dose group, given SWTX 1.25 g/kg for
10 days before I/R; Sham: sham group, rats heart was exposed
by pericardiotomy but without I/R; LS: SWTX with a low dose
group, given SWTX 1.0 g/kg for 10 days before I/R; I/R: I/R inju-
ry group. SWTX: Sanweitanxiang powder; ERK: extracellular
signal-regulated kinases; I/R: ischemia-reperfusion. Each sig-
nal was quantified by scanning densitometry and data de-
note the means±SEM of 2-3 replicate measurements in six dif-
ferent groups. Compared with the sham group, aP<0.01; com-
pared with I/R injury group, bP<0.01.
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search has also suggested that changes in Ca2 + homeo-
stasis play an important role in the modulation of
apoptosis.30 The increased expression of Ca2+ homeosta-
sis proteins could also protect myocardial cells from
apoptosis.
In summary, our study demonstrated that SWTX pre-
treatment protects against I/R injury in rat hearts by ac-
tivating ERK 1/2 and inhibiting apoptosis. Further-
more, our results showed that the protective activities
of SWTX pretreatment might be related to the expres-
sion of proteins involved in Ca2 + homeostasis. Further
research on elucidating the mechanism in detail is on-
going.
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